What does trilink — goodwill impairment mean?

Reflects a non-cash charge recognized when the carrying value of goodwill associated with the TriLink segment exceeds its implied fair value. This indicates a decline in the expected future economic benefits or market outlook for the segment's specific business activities. It serves as a critical signal of potential challenges in the segment's long-term growth trajectory or market competitiveness.

Maravai LifeSciences Holdings, Inc. (MRVI) TriLink — Goodwill impairment

Screener

Other segment segments

Cygnus

$0—

Similar metrics at other companies

LZBRetail — Goodwill impairment

$0—

LZBWholesale — Goodwill impairment

$0-100%

GISInternational — Goodwill impairment

$0—

MDIAAudio — Goodwill impairment

$4.98M—

INVTechnology — Goodwill impairment

$0-100%

ULSConsumer — Goodwill impairment

$0—

Other financials

Income statement

See full

Revenue$51.4M+8.5%

Gross profit$20.7M+166%

Operating income-$15.1M+77.2%

Net income-$12.4M+68.6%

EPS (diluted)-$0.08+70.4%

Balance sheet

See full

Cash & equivalents$70.6M-73.8%

Total debt$176.7M-52.4%

Total equity$204.6M-23.0%

Total assets$603.7M-32.7%

Cash flow

See full

Operating cash flow$4.0M+139%

CapEx$370.0K-87.1%

Free cash flow$3.6M+128%

Valuation

See full

Market cap$918.96M+210%

Enterprise value$1.03B+158%

P/S4.4×+3.1×

Profitability

See full

Gross margin34.9%+4.4pp

Operating margin-56.1%-21.3pp

Net margin-37.1%-13.6pp

FCF margin-17.2%—

Returns & leverage

See full

Return on equity-32.9%-9.4pp

Debt / equity0.9×-0.5×

Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026.

Filed: Feb 26, 2026, 4:06 PM EST
Fiscal year: FY2025
Accession: 0001823239-26-000011

Line item	Tri Link (1)	Cygnus (2)	Total
Balance as of December 31, 2024	$39,950	$119,928	$159,878
Acquisitions	12,207	—	12,207
Impairment	(42,884)	—	(42,884)
Foreign currency translation	228	—	228
Balance as of December 31, 2025	$9,501	$119,928	$129,429

Item 8. Financial Statements and Supplementary Data

FAQ

What is Maravai LifeSciences Holdings, Inc.'s trilink — goodwill impairment?: Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — goodwill impairment of $0 in Q2 2025.
What does trilink — goodwill impairment mean?: Reflects a non-cash charge recognized when the carrying value of goodwill associated with the TriLink segment exceeds its implied fair value. This indicates a decline in the expected future economic benefits or market outlook for the segment's specific business activities. It serves as a critical signal of potential challenges in the segment's long-term growth trajectory or market competitiveness.